125 related articles for article (PubMed ID: 22471464)
1. Talin1, a valuable marker for diagnosis and prognostic assessment of human hepatocelluar carcinomas.
Zhang JL; Qian YB; Zhu LX; Xiong QR
Asian Pac J Cancer Prev; 2011; 12(12):3265-9. PubMed ID: 22471464
[TBL] [Abstract][Full Text] [Related]
2. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY
Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes.
Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY
Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570
[TBL] [Abstract][Full Text] [Related]
4. High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma.
Zhang Y; Liu P; Jiang Y; Dou X; Yan J; Ma C; Fan Q; Wang W; Su F; Tang H; Su X
Pathol Oncol Res; 2016 Apr; 22(2):367-75. PubMed ID: 26563279
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
6. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.
Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236
[TBL] [Abstract][Full Text] [Related]
7. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
8. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.
Cui J; Yu Y; Lu GF; Liu C; Liu X; Xu YX; Zheng PY
Tumour Biol; 2013 Jun; 34(3):1913-8. PubMed ID: 23516026
[TBL] [Abstract][Full Text] [Related]
10. Tissue Levels of Stefin A and Stefin B in Hepatocellular Carcinoma.
Lin YY; Chen ZW; Lin ZP; Lin LB; Yang XM; Xu LY; Xie Q
Anat Rec (Hoboken); 2016 Apr; 299(4):428-38. PubMed ID: 26753874
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma.
He G; Hu S; Zhang D; Wu P; Zhu X; Xin S; Lu G; Ding Y; Liang L
Exp Mol Pathol; 2015 Oct; 99(2):374-82. PubMed ID: 26112097
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma.
Ma H; Liang X; Chen Y; Pan K; Sun J; Wang H; Wang Q; Li Y; Zhao J; Li J; Chen M; Xia J
Int J Cancer; 2011 Feb; 128(4):771-7. PubMed ID: 20473897
[TBL] [Abstract][Full Text] [Related]
14. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of PICT1 in patients of hepatocellular carcinoma with wild-type TP53.
Ishibashi M; Kogo R; Shibata K; Ueo H; Uchi R; Matsumura T; Takano Y; Sawada G; Takahashi Y; Mima K; Kurashige J; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Suzuki A; Wakabayashi G; Mori M; Mimori K
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S537-44. PubMed ID: 23532381
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of BMP7 as an oncogene in hepatocellular carcinoma.
Li W; Cai HX; Ge XM; Li K; Xu WD; Shi WH
Tumour Biol; 2013 Apr; 34(2):669-74. PubMed ID: 23179403
[TBL] [Abstract][Full Text] [Related]
17. Roles of fibroblast growth factor-inducible 14 in hepatocellular carcinoma.
Li N; Hu WJ; Shi J; Xue J; Guo WX; Zhang Y; Guan DX; Liu SP; Cheng YQ; Wu MC; Xie D; Liu SR; Cheng SQ
Asian Pac J Cancer Prev; 2013; 14(6):3509-14. PubMed ID: 23886137
[TBL] [Abstract][Full Text] [Related]
18. IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma.
Hu S; Wu X; Zhou B; Xu Z; Qin J; Lu H; Lv L; Gao Y; Deng L; Yin J; Li G
J Cancer Res Clin Oncol; 2014 Jun; 140(6):883-93. PubMed ID: 24647926
[TBL] [Abstract][Full Text] [Related]
19. EIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinoma.
Cha YL; Li PD; Yuan LJ; Zhang MY; Zhang YJ; Rao HL; Zhang HZ; Zheng XF; Wang HY
PLoS One; 2015; 10(2):e0117493. PubMed ID: 25658620
[TBL] [Abstract][Full Text] [Related]
20. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
Lian J; Jing Y; Dong Q; Huan L; Chen D; Bao C; Wang Q; Zhao F; Li J; Yao M; Qin L; Liang L; He X
Oncotarget; 2016 Jan; 7(3):2672-83. PubMed ID: 26684241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
